Development asset linked to Benitec Biopharma in public FDA and regional records.
biotech · Oculopharyngeal Muscular Dystrophy · Head and Neck Squamous Cell Carcinoma · BNTC
Benitec Biopharma
Benitec Biopharma drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Hayward, USA HQ
2001 Founded
27 Employees
Public company Type
BNTC · NYSE Ticker
Company details
- Status
- Public
- HQ
- Hayward, USA
- Founded
- 2001
- Employees
- 27
- Programs
- 2
- Drugs
- 3
- Patents
- 13
Benitec Biopharma pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Benitec Biopharma drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Benitec Biopharma in public FDA and regional records.
-
Development asset linked to Benitec Biopharma in public FDA and regional records.